About Dr.Agarwal's Health Care

Incorporated in 2010, Dr. Agarwal's Health Care Limited offers a comprehensive range of eye care services, including cataract and refractive surgeries, consultations, diagnoses, non-surgical treatments, and the sale of optical products, contact lenses, accessories, and eye care-related pharmaceutical items.

As of September 30, 2024, there were 737 doctors providing care to patients across the company's facilities. During this period, the company served 2.13 million patients and performed 220,523 surgeries. In the six months leading up to September 30, 2024, they served 1.15 million patients and conducted 140,787 surgeries.

The Services provided by the company are:-

Cataract surgeries Offer cataract surgical treatments at its Facilities, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery and glued intraocular lens treatments;

Refractive surgeries: Refractive surgeries are procedures that correct eye refractive errors, helping individuals reduce or eliminate their need for glasses and contact lenses. The main types include LASIK, SMILE, implantable collamer lenses, and photorefractive keratectomy (PRK).

Other surgeries: Offer a range of other surgical treatments for eye ailments, such as surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty and surgeries for the treatment of glaucoma and pterygium.

As of September 30, 2024, the company's Indian network has 28 hubs (Tertiary Facilities, including three COEs) and 165 spokes (53 Primary and 112 Secondary Facilities).

As of September 30, 2024, the company has a presence in India across 117 metro and non-metro cities spanning 14 states and four union territories through 193 Facilities.

Competitive Strength

Largest eye care services provider in India with a trusted brand
End-to-end, comprehensive eye care services offering
Scalable, asset-light, hub-and-spoke operating model
Proven clinical excellence is driven by a strong clinical board and a history of surgical innovations.
Doctor-promoters leading a team of qualified medical professionals and supported by experienced management
Proven track record of delivering organic growth, integrating and scaling acquisitions and improving operating profitability

Category	Shares Applied	Subscription Times (x)
QIBs Investor	21600	0.00
Total HNIs Investor	760800	0.00
Retail Investor	0	0.00
Shareholders Investor	0	0.00
Employee Investor	0	0.00
Total Subscription	782400	0

Updated on 2026-07-03 13:17:26

Category	Shares Offered	Shares Applied	Subscription Times (x)
QIBs Investor	0	0	0.00
Total HNIs Investor	0	0	0.00
Retail Investor	0	0	0.00
Shareholders Investor	0	0	0.00
Employee Investor	0	0	0.00
Total Subscription	0	0	0

GMP Date	IPO Price	GMP	Estimated Listing Price	Estimated Profit*	Last Updated
11-06-2026	12	₹34	₹46 ( 283.33% )	₹1,190.00	11-Jun-2026 10:23 AM
23-05-2026	200	₹12	₹212 ( 6.00% )	₹420.00	29-May-2026 04:08 PM

Strengths of Company

ndia ki largest eye care service chain me se ek, wide hospital and clinic network ke saath.
Strong brand reputation aur healthcare industry me long operational history.
Comprehensive eye care services: cataract, retina , glaucoma, ,refractive surgeries, cornea treatments
Experienced doctors aur specialist ophthalmologists ki strong team.
Technology-driven treatment infrastructure aur advanced surgical equipment.
Asset-light expansion strategy through clinics and partnerships.
Presence across multiple Indian states aur international markets bhi.

Risks of Company

Experienced doctors aur surgeons par high dependency — key specialists company chhod dein to business impact ho sakta hai.
Healthcare industry heavily regulated hai — government regulations ya compliance changes operations ko affect kar sakte hain.
Medical negligence claims ya legal cases brand reputation aur financials ko impact kar sakte hain.
Expansion strategy fail hone ka risk — naye centers expected performance na dein.

Dr.Agarwal's Health Care FAQs

The Dr.Agarwal's Health Care IPO is a MAIN IPO with a total issue size of ₹ 402 crores. The IPO price band is fixed at ₹382 to ₹402 per share, and the minimum lot size is 35 Shares. The Dr.Agarwal's Health Care IPO will open on 29th Jan 2025, and will close on 31st Jan 2025. Kfin Technologies Ltd. has been appointed as the registrar for the issue. The equity shares are proposed to be listed on NSE.

The Dr.Agarwal's Health Care IPO opens on 29th Jan 2025 and closes on 31st Jan 2025.

The Dr.Agarwal's Health Care IPO lot size is 35 Share, and the minimum amount required for application is ₹ 14880.

You can apply for the Dr.Agarwal's Health Care IPO through your bank account using the ASBA facility or via your online trading and Demat account. To apply online, log in to your broker’s platform, select Dr.Agarwal's Health Care IPO, enter the number of lots, choose your price within the price band, and submit the application. After submitting, approve the UPI mandate to block the required amount in your bank account. Once the IPO allotment is finalised, shares will be credited to your Demat account if allotted. If not allotted, the blocked amount will be released automatically.

The Dr.Agarwal's Health Care IPO listing date is 2nd Apr 2025.